| Dr Robert Steven Olko, MD | |
|
275 North St, Harrison, NY 10528-1524 | |
| (914) 925-5273 | |
| (914) 925-5159 |
| Full Name | Dr Robert Steven Olko |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 275 North St, Harrison, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528125291 | NPI | - | NPPES |
| 00606097 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 106734 (New York) | Primary |
| Entity Name | St Joseph's Hospital Yonkers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356316921 PECOS PAC ID: 0547156176 Enrollment ID: O20040223000340 |
News Archive
A meta-analysis of previous research suggests that use of pioglitazone, a glycemic control medication for patients with type 2 diabetes, significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA: The Journal of the American Medical Association.
A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy (AET) did not get this recommended component of care.
The arthritis drug Vioxx could have caused an estimated 88 000–140 000 excess cases of serious coronary heart disease in the USA since its launch in 1999, concludes a study published online by The Lancet.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for KALYDECOTM (ivacaftor) and granted the company's request for six-month Priority Review.
Zmanda™, the industry's leading provider of open source backup and disaster recovery solutions, today announced that Schryver Medical, Inc. has adopted Amanda Enterprise to backup the company's mission critical enterprise data. The company is also in the process of deploying Zmanda's Disaster Recovery module to ensure they meet all regulatory compliance and uptime requirements.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Steven Olko, MD 275 North St, Harrison, NY 10528-1524 Ph: (914) 925-5273 | Dr Robert Steven Olko, MD 275 North St, Harrison, NY 10528-1524 Ph: (914) 925-5273 |
News Archive
A meta-analysis of previous research suggests that use of pioglitazone, a glycemic control medication for patients with type 2 diabetes, significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA: The Journal of the American Medical Association.
A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy (AET) did not get this recommended component of care.
The arthritis drug Vioxx could have caused an estimated 88 000–140 000 excess cases of serious coronary heart disease in the USA since its launch in 1999, concludes a study published online by The Lancet.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for KALYDECOTM (ivacaftor) and granted the company's request for six-month Priority Review.
Zmanda™, the industry's leading provider of open source backup and disaster recovery solutions, today announced that Schryver Medical, Inc. has adopted Amanda Enterprise to backup the company's mission critical enterprise data. The company is also in the process of deploying Zmanda's Disaster Recovery module to ensure they meet all regulatory compliance and uptime requirements.
› Verified 4 days ago
Dr. Josephine Kuhl, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 600 Mamaroneck Ave, Suite 4, Harrison, NY 10528 Phone: 914-468-0890 Fax: 914-468-0891 | |
Richard Arthur Ellison, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 275 North St, Harrison, NY 10528 Phone: 914-925-5278 Fax: 914-925-5159 | |
Dr. Mia Gintoft Cohen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 450 Mamaroneck Ave Ste 415, Harrison, NY 10528 Phone: 914-407-3047 Fax: 914-499-3900 | |
Christopher S. Aloezos, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 275 North St, Harrison, NY 10528 Phone: 914-925-5261 | |
Dr. James Patrick Kelleher, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 275 North St, Harrison, NY 10528 Phone: 914-925-5278 Fax: 914-925-5159 | |
Dr. Arthur Badikian, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 600 Mamaroneck Ave, Suite 106, Harrison, NY 10528 Phone: 914-948-4277 Fax: 914-948-1633 | |
Irwin Gelman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 275 North St, Harrison, NY 10528 Phone: 914-925-5507 |